Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) under development for ADHD.

Join Dr. Carlos on “Pharmacology Insights,” your source for the latest research and news on pharmacology, medications, and street drugs. Each episode delves into cutting-edge discoveries, practical applications, and the evolving landscape of both legal and illicit substances. Gain a deeper understanding of how drugs work, their impacts on health, and the latest trends in medication and drug use. Tune in for expert analysis and insightful discussions that keep you informed on all things pharmacological.

Share Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) under development for ADHD.

Sign up to save your podcasts

Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) under development for ADHD.

Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) under development for ADHD.

More shows like Pharmacology News

Stuff You Should Know

Psychiatry & Psychotherapy Podcast

Psychiatry Unboxed with TheKicksShrink

Side Effects with Dr. Josef